Celerion Collaborates with South Korea to Strengthen Early Phase Clinical Research
Celerion and the Korean Drug Development Fund announced a formal collaboration
Celerion and the Korean Drug Development Fund (KDDF) announced a formal collaboration to provide drug development expertise and support for the emerging drug discovery and development industry in South Korea. The agreement—in the form of a Memorandum of Understanding (MOU)—provides the framework for collaborations of mutual benefit to both organizations. Companies funded by KDDF will have access to Celerion’s experience and expertise in early clinical research and bioanalysis, as well as the global footprint of external partner sites. The collaboration will focus on developing innovative and efficient ways to bring Korean drug discoveries to the global market.
Read the full release here.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
